REPORT OF A CASE
A male patient (8 years of age at present) who was born on October 22, 1961 after a normal full term pregnancy, weighing 3,200g , first visited our clinic on April 24, 1965 (3 years 6months of age) complaining of severe anemia and jaundice, and was admitted immediately for detailed examinations.
The parents and an elder brother were all in good health. There were no histories of blood disease in his family.
He had developed uneventfully without a history of sickness until2years and 6months of age, when the parents had noticed fever, anemia and jaundice of the patient.
On July 19, 1964, 10 months prior to admission to our hospital, the patient had been diagnosed as having hemolytic anemia of obscure origin and had been treated for 75days.
After that he had been repeatedly attacked by jaundice and anemia, especially on respiratory infec tion.
On admission to our hospital, the patient was markedly anemic and jaundiced. The face was slightly edematous.
The cervical, axillar and inguinal lymph nodes were not swollen. The chest showed no abnormality.
The liver was palpable at 2cm below the costal margin and the spleen was not. The reflexes were normal and pathologic reflexes were not elicited.
Laboratory data on admission
Tuberculin and Wassermann's reactions were negative. Blood sedimentation rate was not accelerated, showing 3mm/1hr. aion, became palpable 3cm below the costal margin. Immediately, the treatment with betamethasone and blood transfusions was started.
At first, betamethasone was given 2 mg daily and some improvement of the symptoms was obtained.
Two weeks later, betamethasone was lowered to 1.5-I mg daily for 3 successive days a week, as shown in Fig.  1 . And then, heparin (160mg in total), 6MP (20mg in total) ACTH Z (200U), etc. were given together with the steroid. However, the symptoms of the patient became worse, showing marked jaundice (more than 6mg/100ml in total bilirubin) and anemia (below 10% in hemoglobin level and less than 1,000,000/mms in red cell count). Consequently, the treatment with both betamethasone in a dose of 2-1 .5mg daily and blood transfusions were started again. And when betamethasone was lowered to 1 .5mg daily, the jaundice and anemia became so worse that the dosage of the steroid must be increased to 3mg daily. After a while, the steroid was again reduced to 1 .5mg daily, and the same results as mentioned above were obtained , but more frequent blood transfusions were requested.
Five months after admission, the spleen was removed on September 25 , 1965. The spleen weighed 160g and the cut surface was purplish red . Histological findings of the spleen were those of typical hemolytic anemia, showing sinus congestion , prominence of sinus endothelium, reticular hyperplasia and hemosiderin pigments .
After splenectomy, betamethasone was given at a dose level of 3mg daily for first 3 months and then reduced to 2mg for 4 successive days a week. However , when the steroid was reduced to 1mg for 4 successive days a week, total bilirubin markedly increased and anemia became marked, as shown in Fig. 2 . Therefore, the steroid was kept again in 2mg for 4 successive days a week for 6months and then gradually reduced to 1 .5mg and finally to 1.25mg in the same regimen. The patient was discharged from the hospital on July 7 , 1966 and thereafter, he was treated at home until he was admitted to our hospital for thymectomy on December 11, 1967 .
The steroid regimen mentioned above was continued for 2years 3months. However , a satisfactory result was not obtained, although the steroid dosage could be reduced to 1 .25 mg for 4 successive days a week from 3mg daily. Frequent admission to the hospital was necessary owing to aggravation of the symptoms, when the patient suffered from respiratory infection or when the dosage of the steroid was lowered to I mg for 4 successive days a week . Stunted growth (body length: 97cm on first admission of April 24, 1965 and 103cm before thymectomy on Dec. 15, 1967) and delayed appearance of ossification centers of the wrist (3 at the age of 6years) were also apparent, in spite of such relatively low dosage as 1.25 mg for 4 successive days a week.
On December 15, 1966, 5years and 1 month of age thymectomy was performed with success. The thymus was markedly atrophic, probably owing to the long-term and intensive steroid therapy.
And contrary to our expectation, characteristic findings of the thymus with autoimmune diseases such as lymphfollicles with germinal centers and plasma and epithelioid cell infiltration, etc. were not found.
After thymectomy, however, the steroid regimen was shortened to 3 successive days a week and the dosage of betamethasone was lowered to 1.25-0.75 mg (Fig. 3 ) Nine months after thymectomy, the dosage of the steroid was further reduced to 0.75mg.
The patient was discharged from our hospital on October 2, 1968. The steroid regimen was maintained for more than 5months with satisfactory results. During the steroid regimen, as shown in Fig. 3 , anemia and jaundice of the patient almost disappeared, although not completely, the body growth (103cm prior to thymectomy, Dec. 15, 1967; 113.5cm 1 year and 6month after thymectomy) and bone age were greatly accelerated and the patient thereafter did not show anemia and jaundice, even when he suffered from respiratory infections. In fact, no further admission to the hospital; blood transfusion was necessary after thymectomy.
However, the disease was not completely healed even by thymectomy. The laboratory studies of the patient in the steroid regimen mentioned above indicated yet evidence of the disease such as elevated reticulocyte count, increased osmotic fragility of the erythrocytes and weak positive direct Coomb's test, in spite of low level of serum bilirubin and increased hemoglobin levels. The reduction of the steroid dosage to 0.5mg for 3 successive days a week was followed by a drop in hemoglobin levels and an increase in serum bilirubin levels. Since then, the steroid regimen of 0.75mg for 3 successive days a week became incompetent to maintain low serum bilirubin level.
The steroid was increased to 1mg and then 1.25mg for 3 successive days a week (Fig. 4) . At the present time (December 25, 1969), the patient is under the satisfactory condition in the steroid regimen of 1.25 mg for 3 successive days a week. However, in spite of the necessity to increase the dosage of the steroid, the patient's condition was fair and he has never been requested to the hopsital and to receive blood transfusions thereafter. COMMENT Recently, thymectomy in the treatment of autoimmune hemolytic anemia has been reported by several authors. Wilmers and Russell9 at first reported beneficial effects of thymectomy on autoimmune hemolytic anemia in an infant at the age of 6 1/2 months. In this case, the disease failed to respond to both splenectomy and steroid therapy over 4months, but thymectomy brought about a complete remission, transfusions being not required and the direct Coomb's test becoming negative 11 weeks after thymectomy.
Karaklis et al. 10 also described an infantile case of autoimmune hemo lytic anemia, which was treated successfully by thymectomy. In this case, direct and indirect Coomb's tests became negative 7months after thymectomy, while splenectomy did not produce a complete, but a temporary remission and the treatment with steroid also failed to bring about an improvement.
As to these beneficial effects of thymectomy on autoimmune hemolytic anemia, Wilmers and Russell9 suggested that their patient might have responded favorably, because she was operated at an age when the thymus has not yet involuted and therefore functional. The normal thymus is known to exert its greatest immunological function in the neonatal period, while later the other lymphoid organs progressively take over that function. However , Karaklis et al.'° stated that the theory mentioned above might not be applied to the diseased organ, because the histological abnormalities in the thymus had been described in autoimmune diseases in adults.
On the other hand, Oski and Abelson" reported a case of autoimmune hemolytic anemia in a 6-week-old infant who failed to attain a remission not only by treatment with steroid, 6 M .P., heparin, antisnake venom and exchange transfusions, but also by splenectomy and thymectomy . They thought that the failure to respond to thymectomy in their case was conflicting with the assumption that the thymus might be a primary source of antibodies in autoimmune hemolytic anemia.
As seen in these reports, thymectomy for autoimmune hemolytic anemia has been hitherto performed only for infants under 1 year of age . However, in our patient in whom severe hemolytic anemia started from 2 years and 8 months of age, thymectomy was performed at 5 years and 1 month of age .
Our own patient was admitted to our hosptial at the age of 3 years and 6 months and during 5 months before splenectomy, the treatment with betamethasone in a dose of 2-3mg daily , heparin, 6 M.P., ACTH, etc. was tried but failed to induce a remission. After splenectomy , the steroid dosage could be reduced from 3mg daily to finally 1.25mg for 4 successive days a week . The regimen was continued for 2years and 3months . However, when the steroid dosage was lowered to 1mg for 4 successive days a week , or when he suffered from respriatory infection, frequent admissions to the hospital and blood transfusions became necessary. And stunted growth and delayed appearance of ossification centers were marked in the steroid regimen mentioned above . Therefore, thymectomy was performed as a last resort to reduce the steroid dosage further.
It should be of special mention that after thymectomy the steroid regimen could be shortened to 3 successive days a week and the dosage of the steroid could be lowered to 0.75mg in our patient, and further that no more blood transfusion or admission to the hospital was required, even when he suffered from respiratory infections. The patient became almost free from anemia and jaundice but he was not completely cured, because elevated reticulocyte count , increased osmotic fragility of the erythrocytes and weak positive direct Coomb's test still indicated enhanced hemolysis. But body growth and bone age were greatly accelerated .
These satisfactory conditions continued for more than 5months . However, when the steroid dosage was reduced to 0 .5mg for 3 successive days a week, the symptoms became worse. And since then, steroid regimen of 0.75mg for 3 succes sive days a week became incompetent to maintain a low serum bilirubin level , and the steroid dosage must be increased to 1.25mg for 3 successive days a week again, although hospitalization and blood transfusion were never neces sary.
From the results, it was clear that thymectomy induced beneficial effects in reducing the steroid dosage, although temporary, and in improving the clinical symptoms in our patient at the age of 6year.
On the other hand, it has been known that autoimmune hemolytic anemia sometimes causes spontaneous remission. Dausset and Colombani12 reported in their statistical studies on 128 cases with autoimmune hemolytic anemia between 1949 and 1958 that out of 83 cases with warm antibody, 27 were cured, 23 died and 30 still had the disease.
Allgood and Chaplin13 reviewed 40 cases aged more than 10 years and obtained the following results: 3 recovered spontaneously; of patients treated with corticosteroids, 84% attained an initial, partial or complete remission following a single course of therapy, but only 16% could maintain the remission after the steroid was discontinued; of the splenectomized patients, 68% attained complete remission and 44% could maintain the remission without supplementary steroid therapy.
However, thymectomy was performed in our patient, as the last resort after splenectomy and steroid therapy over almost 3 years failed to cause complete remission. And the difference in the course of the illness in our patient between before and after thymectomy was so marked that at present the authors are of the opinion that thymectomy favorably influenced the course of the disease.
However, it was also the authors' opinion that thymectomy should not be tried carelessly but only in extremely severe case of autoimmune hemolytic anemia, which does not respond to all the other treatments, because the ultimate ffect of thymecetomy is still obscure and the operation is sometimes associated with risk.
The thymus of our patient was markedly atrophic and showed no characteristic findings of autoimmune diseases such as lymph follicle formation with germinal centers and plasma cell and epithelioid cell infiltrations in the histologic sections. These findings of the thymus were in contrast to those in NZB/BC mice which spontaneously develop a Coomb's positive hemolytic anemia and those in Karaklis et al.'s case,10 which contained plasmoblasts and mature plasma cells, and similar to those in Wilmer and Russell's cases and Oski et al.'s case." The absence of characteristic findings of the thymus in our patient would be due to long-term and intensive steroid therapy.
